ArticleJournal of inherited metabolic disease2025

Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders.

Calogera M Simonaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.